Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print RSS Feed

Breaking News

Related Searches:
Ortho Biotech, NCI Enter Cancer R&D Pact

June 5, 2009
Ortho Biotech Oncology R&D, a unit of Centocor R&D, Inc., has entered into a five-year Cooperative R&D Agreement (CRADA) with the National Cancer Institute (NCI) to research and develop new cell therapy technologies as potential cancer treatments.  Read More »
Lilly

June 5, 2009
Bart Peterson has been appointed senior vice president of corporate affairs and communications, Eli Lilly and Co.   Read More »
Merck's Rolofylline Misses Endpoint

June 5, 2009
Merck's preliminary results for the Phase III study of rolofylline (MK-7418), an investigational medicine for the treatment of acute heart failure, shows that rolofylline did not meet the primary or secondary efficacy endpoints.  Read More »
Abbott, AstraZeneca Expand Cholesterol Pact

June 4, 2009
Abbott and AstraZeneca have entered into an agreement under which the two companies will co-promote Abbott's cholesterol drug Trilipix (fenofibric acid) in the U.S. Financial terms were not disclosed.  Read More »
Astellas Pharma Global Development

June 4, 2009
Dr. Betsy Garofalo has been named as the global therapy area leader for CNS, Astellas Pharma Global Development.  Read More »
OctoPlus Wins Drug Delivery Evaluation Contract

June 4, 2009
OctoPlus N.V. has signed a new drug delivery technology evaluation contract for two compounds with a European biotech company.   Read More »
Astellas Pharma

June 3, 2009
Dan Dunham has been named vice president of compliance at Astellas Pharma US, Inc.   Read More »
Sartorius To Supply Products for H1N1 Vaccine Production

June 3, 2009
Sartorius Stedim Biotech (SSB) received several large orders for consumables used in biopharmaceutical production from leading global vaccine manufacturers.  Read More »
Sentry Changes Name

June 3, 2009
Sentry Logistic Solutions, Inc. has changed its name to Sentry BioPharma Services, Inc. The change is intended to represent the company’s enhanced service offerings and market focus.  Read More »
Genzyme Acquires Campath from Bayer

June 2, 2009
Genzyme Corp. has completed the transaction with Bayer HealthCare to acquire the worldwide rights to Campath.  Read More »
Azopharma Product Development Group

June 2, 2009
Daniel Cammarata, CPA has joined the company as its chief financial officer. Mr. Cammarata will report to Phil Meeks, chief executive officer and will be responsible for overseeing all financial operations for Azopharma Product Development Group and its s  Read More »
IDT Biologika Establishes U.S. Office

June 2, 2009
IDT Biologika has opened new offices outside Washington, DC in Herndon, VA in response to increased demand for the company’s services in the U.S. market.  Read More »
Sparta Systems Launches HK Operations

June 2, 2009
Sparta Systems, Inc. has opened Hong Kong operations to expand its global footprint and to help drive quality and compliance standards in the Asia-Pacific region.   Read More »
MDS Sells Late-Stage Operations

June 1, 2009
MDS, Inc. is divesting its Phase II-IV operations to INC Research for $50 million. MDS plans to focus on early stage discovery through Phase IIa CRO services.   Read More »
Catalent Pharma Solutions

June 1, 2009
Steve Leonard has been appointed senior vice president of Global Operations, Catalent Pharma Solutions. Mr. Leonard will be located at the company’s corporate headquarters in Somerset, NJ.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: